Your browser doesn't support javascript.
loading
Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5.
Wada, Asaka; Hirohashi, Yoshihiko; Kutomi, Goro; Murata, Kenji; Iwabuchi, Sadahiro; Mizue, Yuka; Murai, Aiko; Kyuno, Daisuke; Shima, Hiroaki; Minowa, Tomoyuki; Sasaki, Kenta; Kubo, Terufumi; Kanaseki, Takayuki; Tsukahara, Tomohide; Nakatsugawa, Munehide; Hashimoto, Shinichi; Osanai, Makoto; Torigoe, Toshihiko; Takemasa, Ichiro.
Afiliação
  • Wada A; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hirohashi Y; Department of Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kutomi G; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Murata K; Department of Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Iwabuchi S; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Mizue Y; Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
  • Murai A; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kyuno D; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Shima H; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Minowa T; Department of Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Sasaki K; Department of Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kubo T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kanaseki T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tsukahara T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Nakatsugawa M; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hashimoto S; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Osanai M; Department of Pathology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
  • Torigoe T; Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
  • Takemasa I; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Cancer Sci ; 114(12): 4511-4520, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37991442
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão